Lv6
1632 积分 2022-04-05 加入
Hepatic Amyloidosis Without Hepatomegaly
1个月前
已完结
Treatment Algorithm for Managing Chronic Hepatitis B Virus Infection in the United States: 2021 Update
1个月前
已完结
Early on-treatment LSM reliably predicts liver-related events in CHB patients with significant fibrosis and cirrhosis
1个月前
已完结
Use of liver stiffness measurement for hepatocellular carcinoma risk stratification in metabolic dysfunction associated steatotic liver disease
1个月前
已完结
Causes of mortality among patients with early-stage hepatocellular carcinoma
1个月前
已关闭
Letter to the Editor: Immortal time bias in the management of patients with HCC who achieved CR following immunotherapy-based systemic therapy
1个月前
已完结
Letter to the editor: Interpreting real-world data in advanced HCC— need for clarity on subsequent therapies, adverse events, and follow-up adequacy
1个月前
已关闭
Development and validation of a risk prediction model for patients with hepatocellular carcinoma receiving atezolizumab-bevacizumab
1个月前
已完结
Letter to the editor: Real-world evidence supports nephrotoxic risk of anakinra plus zinc in alcohol-associated hepatitis
1个月前
已关闭
Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time
2个月前
已完结
皖公网安备34019202002308
